Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).
Computer aided drug design led to a new class of spiro-barbiturates (e.g., 4a, MMP-13 K(i)=4.7 nM) that are potent inhibitors of MMP-13.